FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+38%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$30.4B
AUM Growth
+$7.6B
(+33%)
Cap. Flow
+$220M
Cap. Flow
% of AUM
0.73%
Top 10 Holdings %
Top 10 Hldgs %
34%
Holding
622
New
73
Increased
196
Reduced
171
Closed
128
Top Buys
| 1 |
T-Mobile US
TMUS
|
$436M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$150M |
| 3 |
Shake Shack
SHAK
|
$147M |
| 4 |
Datadog
DDOG
|
$140M |
| 5 |
Lowe's Companies
LOW
|
$109M |
Top Sells
| 1 |
Microsoft
MSFT
|
$206M |
| 2 |
NVIDIA
NVDA
|
$160M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$153M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$136M |
| 5 |
CrowdStrike
CRWD
|
$118M |
Sector Composition
| 1 | Technology | 33.43% |
| 2 | Healthcare | 21.84% |
| 3 | Consumer Discretionary | 15% |
| 4 | Communication Services | 9.98% |
| 5 | Financials | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Amgen
AMGN
$153B
| $1.46M | ﹤0.01% |
6,172
+63
| +1% | +$14.9K |
|
327
AT&T
T
$212B
| $1.45M | ﹤0.01% |
63,388
| – | – |
|
328
Adaptive Biotechnologies
ADPT
$1.96B
| $1.36M | ﹤0.01% |
28,171
+8,000
| +40% | +$387K |
|
329
InMode
INMD
$947M
| $1.34M | ﹤0.01% |
94,296
+10,176
| +12% | +$144K |
|
330
Exxon Mobil
XOM
$466B
| $1.34M | ﹤0.01% |
29,849
| – | – |
|
331
Eventbrite
EB
$254M
| $1.29M | ﹤0.01% |
+150,926
| New | +$1.29M |
|
332
McDonald's
MCD
$224B
| $1.27M | ﹤0.01% |
6,896
+68
| +1% | +$12.5K |
|
333
Eaton
ETN
$136B
| $1.24M | ﹤0.01% |
14,179
+4
| +0% | +$350 |
|
334
Akebia Therapeutics
AKBA
$785M
| $1.22M | ﹤0.01% |
90,000
+35,000
| +64% | +$475K |
|
335
GSK
GSK
$81.6B
| $1.2M | ﹤0.01% |
23,466
| – | – |
|
336
Edwards Lifesciences
EW
$47.5B
| $1.18M | ﹤0.01% |
17,095
-15,062
| -47% | -$1.04M |
|
337
Ocular Therapeutix
OCUL
$2.37B
| $1.17M | ﹤0.01% |
140,000
+105,000
| +300% | +$875K |
|
338
Sempra
SRE
$52.9B
| $1.16M | ﹤0.01% |
19,822
| – | – |
|
|
SPLK
339
DELISTED
Splunk Inc
SPLK
| $1.16M | ﹤0.01% |
+5,826
| New | +$1.16M |
|
|
XLRN
340
DELISTED
Acceleron Pharma Inc.
XLRN
| $1.14M | ﹤0.01% |
12,000
+2,000
| +20% | +$191K |
|
341
Fate Therapeutics
FATE
$116M
| $1.14M | ﹤0.01% |
33,166
+5,166
| +18% | +$177K |
|
342
Equinix
EQIX
$75.7B
| $1.1M | ﹤0.01% |
1,567
| – | – |
|
343
Chevron
CVX
$310B
| $1.1M | ﹤0.01% |
12,331
-25
| -0.2% | -$2.23K |
|
344
ConocoPhillips
COP
$116B
| $1.1M | ﹤0.01% |
26,121
| – | – |
|
345
Chefs' Warehouse
CHEF
$2.61B
| $1.09M | ﹤0.01% |
+79,981
| New | +$1.09M |
|
346
Medtronic
MDT
$119B
| $1.08M | ﹤0.01% |
11,803
| – | – |
|
|
CONE
347
DELISTED
CyrusOne Inc Common Stock
CONE
| $1.07M | ﹤0.01% |
14,754
-87
| -0.6% | -$6.33K |
|
348
Lamar Advertising Co
LAMR
$13B
| $1.07M | ﹤0.01% |
16,046
| – | – |
|
|
NVTA
349
DELISTED
Invitae Corporation
NVTA
| $1.06M | ﹤0.01% |
+35,000
| New | +$1.06M |
|
350
Americold
COLD
$3.98B
| $1.06M | ﹤0.01% |
29,131
-76,731
| -72% | -$2.78M |
|